ArticleOncology letters2021

MIF promoter polymorphism increases peripheral blood expression levels, contributing to increased susceptibility and poor prognosis in hepatocellular carcinoma.

Lifeng Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.